Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Biora Therapeutics (BIORQ) Stock Price & Analysis

1,084 Followers

BIORQ Stock Chart & Stats

$0.00-$0.00(-99.00%)
At close: 11:02 AM EDT
$0.1$0.2$0.3May 12May 27Jun 9Jun 23Jul 7Jul 22Aug 4
Day’s Range
$0.12 - $0.12
52-Week Range
$0.08 - $7.10
Previous Close
$0.12
Volume
N/A
Average Volume (3M)
9,816
Market Cap
$452
Enterprise Value
$54.77M
Total Cash (Recent Filing)
$3.20M
Total Debt (Recent Filing)
$39.65M
Price to Earnings (P/E)
0.0
Beta
-56.00
Next Earnings
N/A
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Revenue Growth

The significant revenue growth indicates a strong potential for market expansion and product adoption, which can drive future profitability and enhance competitive positioning in the biotechnology sector.

Innovative Product Development

Biora's focus on innovative therapies and drug delivery systems positions it well to address unmet medical needs, potentially leading to successful partnerships and licensing opportunities that can drive long-term revenue.

Strategic Partnerships

Strategic partnerships with pharmaceutical companies enhance Biora's market reach and distribution capabilities, providing a durable revenue stream and reducing the risk associated with sole reliance on proprietary products.

Bears Say

High Leverage

A highly leveraged balance sheet with negative equity increases financial risk, potentially leading to solvency issues and limiting the company's flexibility to navigate market challenges or invest in new opportunities.

Negative Cash Flow

Consistently negative operating cash flows indicate ongoing liquidity pressures, limiting Biora's ability to fund operations and strategic initiatives without external financing, which could strain future growth.

Financial Instability

The company's financial instability, marked by high leverage and negative cash flows, poses a risk to its ability to sustain operations and invest in growth, potentially impacting long-term viability.

BIORQ FAQ

What was Biora Therapeutics’s price range in the past 12 months?
Biora Therapeutics lowest stock price was $0.08 and its highest was $7.10 in the past 12 months.
What is Biora Therapeutics’s market cap?
Biora Therapeutics’s market cap is $452.
When is Biora Therapeutics’s upcoming earnings report date?
Biora Therapeutics’s next earnings report is estimated for Mar 26, 2025 (not yet confirmed), which is 599 days ago.
How were Biora Therapeutics’s earnings last quarter?
Biora Therapeutics released its earnings results on Nov 14, 2024. The company reported -$6.08 earnings per share for the quarter, missing the consensus estimate of -$3.85 by -$2.23.
Is Biora Therapeutics overvalued?
According to Wall Street analysts Biora Therapeutics’s price is currently Undervalued.
Does Biora Therapeutics pay dividends?
Biora Therapeutics does not currently pay dividends.
What is Biora Therapeutics’s EPS estimate?
Biora Therapeutics’s EPS estimate is -3.50.
How many shares outstanding does Biora Therapeutics have?
Biora Therapeutics has 4,522,702 shares outstanding.
What happened to Biora Therapeutics’s price movement after its last earnings report?
Biora Therapeutics reported an EPS of -$6.08 in its last earnings report, missing expectations of -$3.85. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Biora Therapeutics?
Hedge funds hold Biora Therapeutics shares: the largest hedge-fund position in Biora Therapeutics is 71,856,975 shares, and hedge funds decreased their holdings by 6.2K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology